Professor, Medicine, UCSF School of Medicine
Internal Medicine
Dr. Marion G. Peters, MD
|
|
Give Review
Dr. Marion G. Peters practices Internal Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Marion G. Peters, MD is a published physician. He has 53 papers published. The most current publication "Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin.
- Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for ...
- Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
- Isolated Hepatitis B Core Antibody Status is not Associated with Accelerated Liver Disease Progression in HIV/Hepatitis C Coinfection.
- A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.
- Association of Chronic Hepatitis C Infection With T-Cell Phenotypes in HIV-Negative and HIV-Positive Women.
- Advances in Therapy for HIV-HCV Coinfected Patients in the Liver Transplant Setting.
- Characteristics and Management of Patients with Chronic Hepatitis B in an Integrated Care Setting.
- Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descent.
- Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant Recipients.
- Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.
- Reducing Infection Transmission in Solid Organ Transplantation Through Donor Nucleic Acid Testing: A Cost-Effectiveness Analysis.
- Survey of Asian Patients with Hepatitis B Infection: Limited Knowledge of Transmission and Screening of Family Members.
- Association of HIV infection, HCV infection and Metabolic Factors with Liver Stiffness measured by Transient Elastography.
- Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus.
- Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.
- Racial/Ethnic Differences in Spontaneous HCV Clearance in HIV Infected and Uninfected Women.
- Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.
- Untreated HIV Infection is Associated with Higher Blood Alcohol Levels.
- Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children.
- Provisional Guidance on the Use of Hepatitis C Virus Protease Inhibitors for Treatment of Hepatitis C in HIV-Infected Persons.
- Assessing mortality in women with hepatitis C virus and human immunodeficiency virus using indirect markers of fibrosis.
- Resistance Patterns and Response to Entecavir Intensification Among HIV-HBV-Coinfected Adults With Persistent HBV Viremia.
- The Relation of HLA Genotype to Hepatitis C Viral Load and Markers of Liver Fibrosis in HIV-Infected and HIV-Uninfected Women.
- Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
- Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus.
- Recommendations for prevention, screening, and diagnosis of HBV and HCV infections.
- Entering the new era of therapy for HBV and HCV infections.
- End-stage liver disease in HIV disease.
- Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women's Interagency HIV Study.
- Special populations with hepatitis B virus infection.
- The challenge of diagnosing autoimmune hepatitis: less is more.
- Influence of cannabis use on severity of hepatitis C disease.
- Role of alphavbeta6 integrin in acute biliary fibrosis.
- Diagnosis and management of hepatitis B virus and HIV coinfection.
- Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.
- Viral hepatitis in HIV infection.
- Novel model of antigen-specific induction of bile duct injury.
- Effects of HCV treatment on cytokine expression during HCV/HIV coinfection.
- Eosinophilic hepatitis caused by lamotrigine.
- Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
- Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant.
- Managing hepatitis B coinfection in HIV-infected patients.
- Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.
- Antiviral therapy: nucleotide and nucleoside analogs.
- Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis.
- Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
- Hepatitis C and alcohol: fundamental and translational research directions.
- Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
- Alcohol use and hepatitis C.
- Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the...
- Hepatitis C Viremia Is Associated with Cytomegalovirus IgG Antibody Levels in HIV-Infected Women.
Schools
University Of Melbourne School Of Medicine
Doctors Specialties
- Internal Medicine
Accepted Insurances
- Aetna HMO
- Basic HMO
- Vitalidad Plus California Con Aetna
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Select Plus HMO
- Select PPO
- Access Plus Savenet
- Enhanced Exclusive for Small Business HMO
- Local Access Plus HMO
- Brown & Toland Physicians
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Medicare Advantage PFFS
- WholeCare Network HMO
- Humana
- Medicaid
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Hospital
-
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1548218316 | |
| NPPES Provider LastName | PETERS | |
| NPPES Provider FirstName | MARION | |
| NPPES Provider ZIPCode | 941430001 | |
| NPPES Provider State | CA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 196.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548218316 |
| Last Name Of The Provider | PETERS |
| First Name Of The Provider | MARION |
| View All |
Similar Doctors
|
Dr. James Hansen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank A. Gotch, MD |
|
Dr. Kenneth D. Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald E. Ganem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Isaac R. Whitman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa G. Chui, MD |
|
|
Dr. Shah R. Ali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tien V. Nguyen, MD |
|
|
Dr. Steven C. Pirog, MD |
|
|
Dr. Alyce B. Tarcher, MD
This Doctor is OpenDoctor Recommended.
|